Gilead to charge governments $2,340 for remdesivir – Financial Times

Make informed decisions with the FT

Keep abreast of significant corporate, financial and political developments around the world.
Stay informed and spot emerging risks and opportunities with independent global reporting, expert
commentary and analysis you can trust.